Marks Believes Trump Team Will Not Threaten US FDA’s Medicines Expertise

 
• By Andrew McConaghie
  
CBER Director Peter Marks said he was not worried about rhetoric and that the FDA's high standards would be preserved. (Shutterstock)

More from Elections

More from Legislation